123330 — Genic Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩189bn
- KR₩179bn
- KR₩78bn
Annual cashflow statement for Genic Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4,331 | -3,340 | -4,411 | 7,563 | 18,887 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 5,922 | 2,303 | 1,649 | -962 | -2,762 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -580 | -668 | 692 | -7,965 | 2,557 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,324 | 178 | -268 | 272 | 20,651 |
| Capital Expenditures | -651 | -1,423 | -841 | -1,651 | -2,684 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 12,790 | -2,467 | 2,612 | 132 | -705 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 12,139 | -3,890 | 1,771 | -1,519 | -3,389 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3,694 | -10,193 | -3,167 | 818 | -5,289 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11,750 | -13,839 | -1,681 | -383 | 11,957 |